CymaBay Therapeutics
Why Robinhood?
You can watch CBAY and buy or sell other stocks, ETFs, and their options commission-free!About CBAY
CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001.
CBAY Key Statistics
Stock Snapshot
The current CymaBay Therapeutics(CBAY) stock price is $32.48, with a market capitalization of 3.73B. The stock trades at a price-to-earnings (P/E) ratio of -32.75.
CymaBay Therapeutics(CBAY) stock opened on 2026-07-12 at —. The price climbed to — and dipped to —.
The CymaBay Therapeutics(CBAY)'s current trading volume is 0, compared to an average daily volume of 1.85M.
During the past year, CymaBay Therapeutics(CBAY) stock moved between $7.26 at its lowest and $32.50 at its peak.
During the past year, CymaBay Therapeutics(CBAY) stock moved between $7.26 at its lowest and $32.50 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.